Researchers at the New York State Psychiatric Institute, in New York City, used a meta-analysis to test the hypothesis that eicosapentaenoic acid (EPA) is the effective component in omega-3 fatty acid treatment of major depressive episodes. Continue reading Review: EPA to treat depression→
Researchers at Harvard Medical School, in Boston conducted a review of the 2007 National Health Interview Survey of non-institutionalized US residents conducted by the National Center of Health Statistics of the Center for Disease Control. Continue reading CAM use by Americans→
Emily Matthews, a reader of this blog, provides this overview of depression and complementary treatment options.
About 20 million Americans suffer from clinical depression. Low levels of serotonin, a neurotransmitter, are thought to contribute to depression. Depression is also associated with diseases like diabetes, heart disease, chronic pain, hormonal imbalance, hypoglycemia, stress, impaired thyroid function, environmental toxins, and unhealthy lifestyles. Continue reading CAM options for treating depression→
Dyspnea (difficulty breathing) is a cardinal symptom of chronic obstructive pulmonary disease (COPD). Its severity and magnitude increase as the disease progresses, leading to significant disability and a negative effect on quality of life.